Patent · US Expired

Composition and method for producing an immune response against tumor-related antigens

US7414108B2 · kind B2 · utility

17Cited by
1References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 4, 2004
Grant dateAug 19, 2008
Priority date
Expiry dateNov 30, 2024

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2799/026
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed are a novel prostatic acid phosphatase and corresponding coding region derived from mouse. Also disclosed is a method of producing an immune response against an autologous polypeptide tumor antigen by immunizing a subject with a xenogeneic polypeptide antigen, either alone, as part of a viral antigen construct, or as part of a pulsed dendritic cell preparation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.